Oak Harbor Wealth Partners, LLC Gilead Sciences, Inc. Transaction History
Oak Harbor Wealth Partners, LLC
- $317 Million
- Q2 2024
A detailed history of Oak Harbor Wealth Partners, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Oak Harbor Wealth Partners, LLC holds 3,355 shares of GILD stock, worth $280,511. This represents 0.07% of its overall portfolio holdings.
Number of Shares
3,355
Previous 3,352
0.09%
Holding current value
$280,511
Previous $245,000
6.12%
% of portfolio
0.07%
Previous 0.08%
Shares
10 transactions
Others Institutions Holding GILD
# of Institutions
1,879Shares Held
1.02BCall Options Held
12MPut Options Held
8.96M-
Black Rock Inc. New York, NY121MShares$10.1 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA115MShares$9.64 Billion0.15% of portfolio
-
Capital World Investors Los Angeles, CA76.2MShares$6.38 Billion0.88% of portfolio
-
Capital Research Global Investors Los Angeles, CA60.4MShares$5.05 Billion0.94% of portfolio
-
State Street Corp Boston, MA59.3MShares$4.96 Billion0.18% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $105B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...